FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Talmadge King

Research Profile

Disorders

Anatomy

Procedures

Phenomena

Vital Capacity

Activities & Behaviors

Smoking

Physiology

Concepts & Ideas

Co-author Network

Publications

TOP 3
Joyce S Lee; Kara L Lynch; Luca Richeldi; Christopher J Ryerson; Anthony K Shum; Paul J Wolters; Brett M Elicker; Kirk D Jones; Tamiko R Katsumoto; Eunice J Kim; Talmadge E King; Stefania Cerri; Harold R Collard
Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis.
Moisés Selman; Annie Pardo; Talmadge E King
Hypersensitivity pneumonitis: insights in diagnosis and pathobiology.
Kevin J Anstrom; Talmadge E King; Joseph A Lasky; Ganesh Raghu; Fernando J Martinez
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Talmadge King (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Joyce S Lee; Kara L Lynch; Luca Richeldi; Christopher J Ryerson; Anthony K Shum; Paul J Wolters; Brett M Elicker; Kirk D Jones; Tamiko R Katsumoto; Eunice J Kim; Talmadge E King; Stefania Cerri; Harold R Collard
Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis.
Respiratory medicine 2013;107(2):249-55.
2012: Moisés Selman; Annie Pardo; Talmadge E King
Hypersensitivity pneumonitis: insights in diagnosis and pathobiology.
American journal of respiratory and critical care medicine 2012;186(4):314-24.
2012: Kevin J Anstrom; Talmadge E King; Joseph A Lasky; Ganesh Raghu; Fernando J Martinez
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
The New England journal of medicine 2012;366(21):1968-77.
2012: Brett Ley; Venerino Poletti; Christopher J Ryerson; Jay H Ryu; Sara Tomassetti; Eric Vittinghoff; Brett M Elicker; Kirk D Jones; Talmadge E King; Joyce S Lee; Matteo Buccioli; Harold R Collard
A multidimensional index and staging system for idiopathic pulmonary fibrosis.
Annals of internal medicine 2012;156(10):684-91.
2012: Ganesh Raghu; Kevin J Anstrom; Harold R Collard; Kevin R Flaherty; Thomas R Fleming; Talmadge E King; Fernando J Martinez; Kevin K Brown
Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials.
American journal of respiratory and critical care medicine 2012;185(10):1044-8.
2012: Luca Richeldi; Christopher J Ryerson; Jay H Ryu; Paul J Wolters; Brett M Elicker; Kirk D Jones; Talmadge E King; Laura L Koth; Joyce S Lee; Brett Ley; Harold R Collard
Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis.
Thorax 2012;67(5):407-11.
2012: Talmadge E King; Harold R Collard; Luca Richeldi
Interstitial lung diseases. Preface.
Clinics in chest medicine 2012;33(1):xiii.
2012: J S Lee; J W Song; P J Wolters; Brett M Elicker; D S Kim; Talmadge E King; Harold R Collard
Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2012;39(2):352-8.
2011: Talmadge E King; Annie Pardo; Moisés Selman
Idiopathic pulmonary fibrosis.
Lancet 2011;378(9807):1949-61.
2011: Roland M Du Bois; Alex Kartashov; Carlo Albera; Williamson Z Bradford; Ulrich Costabel; Lisa Lancaster; Paul W Noble; Ganesh Raghu; Steven A Sahn; Javier Szwarcberg; Michiel Thomeer; Dominique Valeyre; Derek Weycker; Talmadge E King
Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis.
American journal of respiratory and critical care medicine 2011;184(4):459-66.
2011: Talmadge E King; Isabelle Leconte; David A Lynch; Fernando D Martinez; Adele Morganti; Ganesh Raghu; Sébastien Roux; Dominique Valeyre; Kevin K Brown; Roland M du Bois; Jürgen Behr
BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis.
American journal of respiratory and critical care medicine 2011;184(1):92-9.
2011: Paul W Noble; Carlo Albera; Williamson Z Bradford; Ulrich Costabel; Marilyn Glassberg Csete; David Kardatzke; Talmadge E King; Lisa Lancaster; Steven A Sahn; Javier Szwarcberg; Dominique Valeyre; Roland M du Bois
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Lancet 2011;377(9779):1760-9.
2011: Roland M du Bois; Derek Weycker; Carlo Albera; Williamson Z Bradford; Ulrich Costabel; Alex Kartashov; Lisa Lancaster; Paul W Noble; Steven A Sahn; Javier Szwarcberg; Michiel Thomeer; Dominique Valeyre; Talmadge E King
Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference.
American journal of respiratory and critical care medicine 2011;183(9):1231-7.
2011: Talmadge E King
Smoking and subclinical interstitial lung disease.
The New England journal of medicine 2011;364(10):968-70.
2011: Brett Ley; Harold R Collard; Talmadge E King
Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
American journal of respiratory and critical care medicine 2011;183(4):431-40.
2010: Richard J Castriotta; Basil A Eldadah; W Michael Foster; Jeffrey B Halter; William R Hazzard; James P Kiley; Talmadge E King; Frances McFarland Horne; Susan G Nayfield; Herbert Y Reynolds; Kenneth E Schmader; Galen Toews; Kevin P High
Workshop on idiopathic pulmonary fibrosis in older adults.
Chest 2010;138(3):693-703.
2010: Harold R Collard; Carolyn S Calfee; Paul J Wolters; Jin Woo Song; Sang-Bum Hong; Sandra Brady; Akitoshi Ishizaka; Kirk D Jones; Talmadge E King; Michael A Matthay; Dong Soon Kim
Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis.
American journal of physiology. Lung cellular and molecular physiology 2010;299(1):L3-7.
2010: Mehrdad Arjomandi; James Seward; Michael B Gotway; Stephen Nishimura; George P Fulton; Josef Thundiyil; Talmadge E King; Philip Harber; John Balmes
Low prevalence of chronic beryllium disease among workers at a nuclear weapons research and development facility.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 2010;52(6):647-52.
2010: Joyce S Lee; Harold R Collard; Ganesh Raghu; Matthew P Sweet; Steven R Hays; Guilherme M Campos; Jeffrey A Golden; Talmadge E King
Does chronic microaspiration cause idiopathic pulmonary fibrosis?
The American journal of medicine 2010;123(4):304-11.
2010: Brent W Kinder; Cyrus Shariat; Harold R Collard; Laura L Koth; Paul J Wolters; Jeffrey A Golden; Ralph J Panos; Talmadge E King
Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function.
Lung 2010;188(2):143-9.
2010: Wendy Levinson; Talmadge E King; Lee Goldman; Allan H Goroll; Bruce Kessler
Clinical decisions. American Board of Internal Medicine maintenance of certification program.
The New England journal of medicine 2010;362(10):948-52.
2010: Jeffrey J Swigris; Frederick S Wamboldt; Jürgen Behr; Roland M Du Bois; Talmadge E King; Ganesh Raghu; Kevin K Brown
The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference.
Thorax 2010;65(2):173-7.
2010: Jeffrey J Swigris; Kevin K Brown; Jürgen Behr; Roland M du Bois; Talmadge E King; Ganesh Raghu; Frederick S Wamboldt
The SF-36 and SGRQ: validity and first look at minimum important differences in IPF.
Respiratory medicine 2010;104(2):296-304.
2010: Ganesh Raghu; Talmadge E King; Jürgen Behr; Kevin K Brown; Roland M Du Bois; I Leconte; S Roux; Jeffrey J Swigris
Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1).
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2010;35(1):118-23.
2009: Eunice J Kim; Harold R Collard; Talmadge E King
Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern.
Chest 2009;136(5):1397-405.
2009: John D Buckley; Doreen J Addrizzo-Harris; Alison S Clay; J Randall Curtis; Robert M Kotloff; Scott M Lorin; Susan Murin; Curtis N Sessler; Paul L Rogers; Mark Rosen; Antoinette Spevetz; Talmadge E King; Atul Malhotra; Polly E Parsons
Multisociety task force recommendations of competencies in Pulmonary and Critical Care Medicine.
American journal of respiratory and critical care medicine 2009;180(4):290-5.
2009: Talmadge E King; Carlo Albera; Williamson Z Bradford; Ulrich Costabel; Phil Hormel; Lisa Lancaster; Paul W Noble; Steven A Sahn; Javier Szwarcberg; Michiel Thomeer; Dominique Valeyre; Roland M du Bois
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial.
Lancet 2009;374(9685):222-8.
2009: Brent W Kinder; Kevin K Brown; Francis X McCormack; Joachim H Ix; Alma Kervitsky; Marvin I Schwarz; Talmadge E King
Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis.
Chest 2009;135(6):1557-63.
2008: Talmadge E King
Bosentan for idiopathic pulmonary fibrosis.
Current opinion in investigational drugs (London, England : 2000) 2008;9(11):1171-9.
2008: William D Travis; Gary W Hunninghake; Talmadge E King; David A Lynch; Thomas V Colby; Jeffrey Galvin; Kevin K Brown; Man Pyo Chung; Jean-François Cordier; Roland M Du Bois; Kevin R Flaherty; Teri J Franks; David Hansell; Thomas E Hartman; Ella Annabelle Kazerooni; Dong Soon Kim; Masanori Kitaichi; Takashi Koyama; Fernando J Martinez; Sonoko Nagai; David E Midthun; Nestor L Müller; Andrew G Nicholson; Ganesh Raghu; Moisés Selman; Athol Wells
Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project.
American journal of respiratory and critical care medicine 2008;177(12):1338-47.
2008: Brent W Kinder; Talmadge E King
Prognostic significance of bronchoalveolar lavage cellular analysis in scleroderma lung disease.
American journal of respiratory and critical care medicine 2008;177(11):1292-3; author reply 1293.
2008: Brent W Kinder; Kevin K Brown; Marvin I Schwarz; Joachim H Ix; Alma Kervitsky; Talmadge E King
Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis.
Chest 2008;133(1):226-32.
2008: Talmadge E King; Jürgen Behr; Kevin K Brown; Roland M Du Bois; Lisa Lancaster; Joao A de Andrade; Gerd Stähler; Isabelle Leconte; Sébastien Roux; Ganesh Raghu
BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis.
American journal of respiratory and critical care medicine 2008;177(1):75-81.
2008: Ana C Zamora; Paul wolters; Harold R Collard; M Kari Connolly; Brett M Elicker; W Richard Webb; Talmadge E King; Jeffrey A Golden
Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease.
Respiratory medicine 2008;102(1):150-5.
2007: Roland M Du Bois; Talmadge E King
Challenges in pulmonary fibrosis x 5: the NSIP/UIP debate.
Thorax 2007;62(11):1008-12.
2007: Harold R Collard; Bethany B Moore; Kevin R Flaherty; Kevin K Brown; Robert J Kaner; Talmadge E King; Joseph A Lasky; James E Loyd; Imre Noth; Mitchell A Olman; Ganesh Raghu; Jesse Roman; Jay H Ryu; David A Zisman; Gary W Hunninghake; Thomas V Colby; Jim J Egan; David Hansell; Takeshi Johkoh; Naftali Kaminski; Dong Soon Kim; Yasuhiro Kondoh; David A Lynch; Joachim Müller-Quernheim; Jeffrey L Myers; Andrew G Nicholson; Moisés Selman; Galen Toews; Athol U Wells; Fernando J Martinez
Acute exacerbations of idiopathic pulmonary fibrosis.
American journal of respiratory and critical care medicine 2007;176(7):636-43.
2007: Brent W Kinder; Harold R Collard; Laura L Koth; David I Daikh; Paul wolters; Brett Elicker; Kirk D Jones; Talmadge E King
Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?
American journal of respiratory and critical care medicine 2007;176(7):691-7.
2007: Harold R Collard; James E Loyd; Talmadge E King; Lisa H Lancaster
Current diagnosis and management of idiopathic pulmonary fibrosis: a survey of academic physicians.
Respiratory medicine 2007;101(9):2011-6.
2007: Brent W Kinder; Michelle M Freemer; Talmadge E King; Raymond F Lum; Joanne Nititham; Kim Taylor; Jeffrey C Edberg; S Louis Bridges; Lindsey A Criswell
Clinical and genetic risk factors for pneumonia in systemic lupus erythematosus.
Arthritis and rheumatism 2007;56(8):2679-86.
2007: Michael B Gotway; Michelle M Freemer; Talmadge E King
Challenges in pulmonary fibrosis. 1: Use of high resolution CT scanning of the lung for the evaluation of patients with idiopathic interstitial pneumonias.
Thorax 2007;62(6):546-53.
2007: Kevin R Flaherty; Adin-Cristian Andrei; Talmadge E King; Ganesh Raghu; Thomas V Colby; Athol Wells; Nadir Bassily; Kevin Brown; Roland du Bois; Andrew Flint; Steven E Gay; Barry H Gross; Ella Annabelle Kazerooni; Robert Knapp; Edmund Louvar; David Lynch; Andrew G Nicholson; John Quick; Victor J Thannickal; William D Travis; James Vyskocil; Frazer A Wadenstorer; Jeffrey Wilt; Galen Toews; Susan Murray; Fernando J Martinez
Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis?
American journal of respiratory and critical care medicine 2007;175(10):1054-60.
2007: Joshua Portnoy; Kristen L Veraldi; Marvin I Schwarz; Carlyne D Cool; Douglas Curran-Everett; Reuben M Cherniack; Talmadge E King; Kevin K Brown
Respiratory bronchiolitis-interstitial lung disease: long-term outcome.
Chest 2007;131(3):664-71.
2007: Carolyn S Calfee; Sanjiv J Shah; Paul wolters; Sanjay Saint; Talmadge E King
Clinical problem-solving. Anchors away.
The New England journal of medicine 2007;356(5):504-9.
2007: Moisés Selman; Guillermo Carrillo; Andrea Estrada; Mayra Mejia; Carina Becerril; Jose Cisneros; Miguel Gaxiola; Rogelio Pérez-Padilla; Carmen Navarro; Thomas Richards; James H Dauber; Talmadge E King; Annie Pardo; Naftali Kaminski
Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern.
PloS one 2007;2(5):e482.
2007: A C Zamora; Harold R Collard; Paul wolters; W Richard Webb; Talmadge E King
Neurofibromatosis-associated lung disease: a case series and literature review.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2007;29(1):210-4.
2007: Rafael L Perez; Anthony P Kimani; Talmadge E King; Samuel M Aguayo; Jesse Roman
Bronchoalveolar lavage fluid D dimer levels are higher and more prevalent in black patients with pulmonary sarcoidosis.
Respiration; international review of thoracic diseases 2007;74(3):297-303.
2006: Brent W Kinder; Harold R Collard; Talmadge E King
Anticoagulant therapy and idiopathic pulmonary fibrosis.
Chest 2006;130(1):302-3.
2006: Nicholas Walter; Harold R Collard; Talmadge E King
Current perspectives on the treatment of idiopathic pulmonary fibrosis.
Proceedings of the American Thoracic Society 2006;3(4):330-8.
2006: Dong Soon Kim; Harold R Collard; Talmadge E King
Classification and natural history of the idiopathic interstitial pneumonias.
Proceedings of the American Thoracic Society 2006;3(4):285-92.
2006: Michelle M Freemer; Talmadge E King; Lindsey A Criswell
Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus.
Annals of the rheumatic diseases 2006;65(5):581-4.
2006: Donald E Wesson; Talmadge E King; Robert F Todd; Esther A Torres; David B Hellmann; John M Flack; Thomas D Dubose; Victor Schuster
Achieving diversity in academic internal medicine: recommendations for leaders.
The American journal of medicine 2006;119(1):76-81.
2005: Nirav R Shah; Paul Noble; Robert Jackson; Talmadge E King; Steven D Nathan; Maria Padilla; Ganesh Raghu; Melissa Bruce Rhodes; Marvin Schwarz; Gregory Tino; Robert W Dubois
A critical assessment of treatment options for idiopathic pulmonary fibrosis.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG / World Association of Sarcoidosis and Other Granulomatous Disorders 2005;22(3):167-74.
2005: Carlos E Girod; Talmadge E King
COPD: a dust-induced disease?
Chest 2005;128(4):3055-64.
2005: David A Lynch; J David Godwin; Sharon Safrin; Karen M Starko; Phil Hormel; Kevin K Brown; Ganesh Raghu; Talmadge E King; Williamson Z Bradford; David A Schwartz; W Richard Webb
High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis.
American journal of respiratory and critical care medicine 2005;172(4):488-93.
2005: Talmadge E King
Clinical advances in the diagnosis and therapy of the interstitial lung diseases.
American journal of respiratory and critical care medicine 2005;172(3):268-79.
2005: David A Lynch; William D Travis; Nestor L Müller; Jeffrey Galvin; David Hansell; Philippe A Grenier; Talmadge E King
Idiopathic interstitial pneumonias: CT features.
Radiology 2005;236(1):10-21.
2005: Fernando J Martinez; Sharon Safrin; Derek Weycker; Karen M Starko; Williamson Z Bradford; Talmadge E King; Kevin R Flaherty; David A Schwartz; Paul W Noble; Ganesh Raghu; Kevin K Brown
The clinical course of patients with idiopathic pulmonary fibrosis.
Annals of internal medicine 2005;142(12 Pt 1):963-7.
2005: Talmadge E King; Sharon Safrin; Karen M Starko; Kevin K Brown; Paul W Noble; Ganesh Raghu; David A Schwartz
Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis.
Chest 2005;127(1):171-7.
2004: Talmadge E King; Margaret B Wheeler
Inequality in health care: unjust, inhumane, and unattended!
Annals of internal medicine 2004;141(10):815-7.
2004: Kevin R Flaherty; Talmadge E King; Ganesh Raghu; Joseph P Lynch; Thomas V Colby; William D Travis; Barry H Gross; Ella Annabelle Kazerooni; Galen Toews; Qi Long; Susan Murray; Vibha N Lama; Steven E Gay; Fernando J Martinez
Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?
American journal of respiratory and critical care medicine 2004;170(8):904-10.
2004: Harold R Collard; Jay H Ryu; William W Douglas; Marvin I Schwarz; Douglas Curran-Everett; Talmadge E King; Kevin K Brown
Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis.
Chest 2004;125(6):2169-74.
2004: Jason S Vourlekis; Marvin I Schwarz; Reuben M Cherniack; Douglas Curran-Everett; Carlyne D Cool; Rubin M Tuder; Talmadge E King; Kevin K Brown
The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis.
The American journal of medicine 2004;116(10):662-8.
2004: Talmadge E King; Todd A Dickinson; Thomas D DuBose; John M Flack; David B Hellmann; Rubens J Pamies; Robert F Todd; Esther A Torres; Donald E Wesson
The case for diversity in academic internal medicine.
The American journal of medicine 2004;116(4):284-9.
2004: Ganesh Raghu; Kevin K Brown; Williamson Z Bradford; Karen M Starko; Paul W Noble; David A Schwartz; Talmadge E King
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis.
The New England journal of medicine 2004;350(2):125-33.
2004: Talmadge E King
Idiopathic interstitial pneumonias: progress in classification, diagnosis, pathogenesis and management.
Transactions of the American Clinical and Climatological Association 2004;115():43-76; discussion 76-8.
2003: Talmadge E King
Miscellaneous causes of bronchiolitis: inhalational, infectious, drug-induced, and idiopathic.
Seminars in respiratory and critical care medicine 2003;24(5):567-76.
2003: Gary W Hunninghake; David A Lynch; Jeffrey Galvin; Barry H Gross; Nestor Müller; David A Schwartz; Talmadge E King; Joseph P Lynch; Richard Hegele; James Waldron; Thomas V Colby; James C Hogg
Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia.
Chest 2003;124(4):1215-23.
2003: David G Morris; Robert M Jasmer; Laurence Huang; Michael B Gotway; Stephen Nishimura; Talmadge E King
Sarcoidosis following HIV infection: evidence for CD4+ lymphocyte dependence.
Chest 2003;124(3):929-35.
2003: Harold R Collard; Talmadge E King; Becki Bucher Bartelson; Jason S Vourlekis; Marvin I Schwarz; Kevin K Brown
Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis.
American journal of respiratory and critical care medicine 2003;168(5):538-42.
2003: Harold R Collard; Talmadge E King
Demystifying idiopathic interstitial pneumonia.
Archives of internal medicine 2003;163(1):17-29.
2002: Yoshikazu Inoue; Talmadge E King; Elizabeth Barker; Elaine Daniloff; Lee Newman
Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis.
American journal of respiratory and critical care medicine 2002;166(5):765-73.
2002: Helen-Ann Brown Epstein; Peter B Bitterman; Brooke Mossman; Marvin I Schwarz; Dean Sheppard; Laura A Almasy; Harold A Chapman; Scott L Friedman; Talmadge E King; Leslie A Leinwand; Lance Liotta; George R Martin; David A Schwartz; Gregory Schultz; Carston R Wagner; Robert A Musson
Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group.
American journal of respiratory and critical care medicine 2002;166(2):236-46.
2002: Talmadge E King
Nonspecific interstitial pneumonia and systemic sclerosis.
American journal of respiratory and critical care medicine 2002;165(12):1578-9.
2002: Talmadge E King
Racial disparities in clinical trials.
The New England journal of medicine 2002;346(18):1400-2.
2002: Jason S Vourlekis; Marvin I Schwarz; Carlyne D Cool; Rubin M Tuder; Talmadge E King; Kevin K Brown
Nonspecific interstitial pneumonitis as the sole histologic expression of hypersensitivity pneumonitis.
The American journal of medicine 2002;112(6):490-3.
2001: Michelle M Freemer; Talmadge E King
The ACCESS study: characterization of sarcoidosis in the United States.
American journal of respiratory and critical care medicine 2001;164(10 Pt 1):1754-5.
2001: Harold R Collard; Talmadge E King
Lung biopsy in patients with usual interstitial pneumonia.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2001;18(5):895-8.
2001: Talmadge E King; J A Tooze; Marvin I Schwarz; K R Brown; Reuben M Cherniack
Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model.
American journal of respiratory and critical care medicine 2001;164(7):1171-81.
2001: Talmadge E King; Marvin I Schwarz; K Brown; J A Tooze; T V Colby; J A Waldron; Andrew Flint; W Thurlbeck; Reuben M Cherniack
Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality.
American journal of respiratory and critical care medicine 2001;164(6):1025-32.
2001: Harold R Collard; Talmadge E King
The clinical significance of histopathologic subgroups in idiopathic interstitial pneumonia: is surgical lung biopsy essential?
Seminars in respiratory and critical care medicine 2001;22(4):347-56.
2001: Gary W Hunninghake; M B Zimmerman; David A Schwartz; Talmadge E King; J Lynch; R Hegele; J Waldron; T Colby; N Müller; D Lynch; Jeffrey Galvin; Barry H Gross; J Hogg; Galen Toews; Richard A Helmers; J A Cooper; R Baughman; Charlton B. Strange; M Millard
Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis.
American journal of respiratory and critical care medicine 2001;164(2):193-6.
2001: Harold R Collard; Talmadge E King
Treatment of idiopathic pulmonary fibrosis: the rise and fall of corticosteroids.
The American journal of medicine 2001;110(4):326-8.
2001: M Selman; Talmadge E King; A Pardo
Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy.
Annals of internal medicine 2001;134(2):136-51.
2000: Jason S Vourlekis; Kevin K Brown; Carlyne D Cool; D A Young; Reuben M Cherniack; Talmadge E King; Marvin I Schwarz
Acute interstitial pneumonitis. Case series and review of the literature.
Medicine 2000;79(6):369-78.
1998: Talmadge E King
Update in pulmonary medicine.
Annals of internal medicine 1998;129(10):806-12.
1998: ST Uh; Y Inoue; Talmadge E King; Edward D Chan; Lee Newman; David W H Riches
Morphometric analysis of insulin-like growth factor-I localization in lung tissues of patients with idiopathic pulmonary fibrosis.
American journal of respiratory and critical care medicine 1998;158(5 Pt 1):1626-35.
1998: Andrea J Cohen; Talmadge E King; LB Gilman; Catherine Magill; York E Miller
High expression of neutral endopeptidase in idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells.
American journal of respiratory and critical care medicine 1998;158(5 Pt 1):1593-9.
1998: Andrew P Fontenot; C Jennings; Talmadge E King
Pulmonary opacities and glomerulonephritis in a 15-year-old boy.
Chest 1998;113(2):525-7.
1997: J A Martinez; Talmadge E King; K Brown; C A Jennings; L Borish; R L Mortenson; T Z Khan; T W Bost; David W H Riches
Increased expression of the interleukin-10 gene by alveolar macrophages in interstitial lung disease.
The American journal of physiology 1997;273(3 Pt 1):L676-83.
1997: C A Jennings; Talmadge E King; Rubin M Tuder; Reuben M Cherniack; Marvin I Schwarz
Diffuse alveolar hemorrhage with underlying isolated, pauciimmune pulmonary capillaritis.
American journal of respiratory and critical care medicine 1997;155(3):1101-9.
1997: R Tomioka; Talmadge E King
Gold-induced pulmonary disease: clinical features, outcome, and differentiation from rheumatoid lung disease.
American journal of respiratory and critical care medicine 1997;155(3):1011-20.
1996: Y Inoue; Talmadge E King; SS Tinkle; K Dockstader; Lee Newman
Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders.
The American journal of pathology 1996;149(6):2037-54.
1996: Talmadge E King
A lung biopsy is necessary in the management of ANCA-positive patients with chest roentgenographic abnormalities.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG / World Association of Sarcoidosis and Other Granulomatous Disorders 1996;13(3):238-40.
1996: J E Fitzgerald; Talmadge E King; David A Lynch; Rubin M Tuder; Marvin I Schwarz
Diffuse panbronchiolitis in the United States.
American journal of respiratory and critical care medicine 1996;154(2 Pt 1):497-503.
1996: R S Crausman; C A Jennings; R L Mortenson; L M Ackerson; CG Irvin; Talmadge E King
Lymphangioleiomyomatosis: the pathophysiology of diminished exercise capacity.
American journal of respiratory and critical care medicine 1996;153(4 Pt 1):1368-76.
1996: Y Inoue; M Cornebise; E Daniloff; J Lloyd; SS Tinkle; Talmadge E King; Lee Newman
Mast cell-associated basic fibroblast growth factor in the fibrotic response to environmental toxins. The Beryllium Model.
Chest 1996;109(3 Suppl):43S-44S.
1996: R S Crausman; David A Lynch; R L Mortenson; Talmadge E King; CG Irvin; V A Hale; J D Newell
Quantitative CT predicts the severity of physiologic dysfunction in patients with lymphangioleiomyomatosis.
Chest 1996;109(1):131-7.
1996: R S Crausman; C A Jennings; Rubin M Tuder; L M Ackerson; CG Irvin; Talmadge E King
Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology.
American journal of respiratory and critical care medicine 1996;153(1):426-35.
1995: S M Bernstein; J D Newell; D Adamczyk; R L Mortenson; Talmadge E King; David A Lynch
How common are renal angiomyolipomas in patients with pulmonary lymphangiomyomatosis?
American journal of respiratory and critical care medicine 1995;152(6 Pt 1):2138-43.
1995: K Ohta; R L Mortenson; R A Clark; N Hirose; Talmadge E King
Immunohistochemical identification and characterization of smooth muscle-like cells in idiopathic pulmonary fibrosis.
American journal of respiratory and critical care medicine 1995;152(5 Pt 1):1659-65.
1995: David A Lynch; J D Newell; P M Logan; Talmadge E King; N L Müller
Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis?
AJR. American journal of roentgenology 1995;165(4):807-11.
1995: Francis X McCormack; Talmadge E King; B L Bucher; L Nielsen; Robert J Mason; F X McCormac
Surfactant protein A predicts survival in idiopathic pulmonary fibrosis.
American journal of respiratory and critical care medicine 1995;152(2):751-9.
1995: Reuben M Cherniack; T V Colby; Andrew Flint; W M Thurlbeck; J A Waldron; L Ackerson; Marvin I Schwarz; Talmadge E King
Correlation of structure and function in idiopathic pulmonary fibrosis.
American journal of respiratory and critical care medicine 1995;151(4):1180-8.
1994: J M Forrester; Y Wang; N Ricalton; J E Fitzgerald; J Loveless; Lee Newman; Talmadge E King; Brian L Kotzin
TCR expression of activated T cell clones in the lungs of patients with pulmonary sarcoidosis.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(9):4291-302.
1994: Lee Newman; C Bobka; B Schumacher; E Daniloff; B Zhen; Margaret M Mroz; Talmadge E King
Compartmentalized immune response reflects clinical severity of beryllium disease.
American journal of respiratory and critical care medicine 1994;150(1):135-42.
1994: A J Cohen; Talmadge E King; G P Downey
Rapidly progressive bronchiolitis obliterans with organizing pneumonia.
American journal of respiratory and critical care medicine 1994;149(6):1670-5.
1994: Kavita Garg; David A Lynch; J D Newell; Talmadge E King
Proliferative and constrictive bronchiolitis: classification and radiologic features.
AJR. American journal of roentgenology 1994;162(4):803-8.
1994: P C Carré; Talmadge E King; R Mortensen; David W H Riches
Cryptogenic organizing pneumonia: increased expression of interleukin-8 and fibronectin genes by alveolar macrophages.
American journal of respiratory cell and molecular biology 1994;10(1):100-5.
1994: J F Wade; Talmadge E King
Dyspnea, cough, and interstitial lung disease in a 32-year-old smoker.
Chest 1994;105(1):265-7.
1993: Talmadge E King
Respiratory bronchiolitis-associated interstitial lung disease.
Clinics in chest medicine 1993;14(4):693-8.
1993: Talmadge E King
Overview of bronchiolitis.
Clinics in chest medicine 1993;14(4):607-10.
1993: M Kraft; R L Mortenson; T V Colby; L Newman; J A Waldron; Talmadge E King
Cryptogenic constrictive bronchiolitis. A clinicopathologic study.
The American review of respiratory disease 1993;148(4 Pt 1):1093-101.
1993: J F Wade; Talmadge E King
Infiltrative and interstitial lung disease in the elderly patient.
Clinics in chest medicine 1993;14(3):501-21.
1993: Marvin I Schwarz; R L Mortenson; T V Colby; J A Waldron; David A Lynch; M P Hutt; Reuben M Cherniack; Talmadge E King
Pulmonary capillaritis. The association with progressive irreversible airflow limitation and hyperinflation.
The American review of respiratory disease 1993;148(2):507-11.
1993: J M Forrester; Lee Newman; Y Wang; Talmadge E King; Brian L Kotzin
Clonal expansion of lung V delta 1+ T cells in pulmonary sarcoidosis.
The Journal of clinical investigation 1993;91(1):292-300.
1992: Talmadge E King
Restrictive lung disease in pregnancy.
Clinics in chest medicine 1992;13(4):607-22.
1992: D L Buschman; G Gamsu; J A Waldron; J S Klein; Talmadge E King
Chronic hypersensitivity pneumonitis: use of CT in diagnosis.
AJR. American journal of roentgenology 1992;159(5):957-60.
1992: S M Aguayo; Y E Miller; J A Waldron; R M Bogin; M E Sunday; G W Staton; W R Beam; Talmadge E King
Brief report: idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease.
The New England journal of medicine 1992;327(18):1285-8.
1992: D M Hyde; Talmadge E King; T McDermott; J A Waldron; T V Colby; W M Thurlbeck; W M Flint; L Ackerson; Reuben M Cherniack
Idiopathic pulmonary fibrosis. Quantitative assessment of lung pathology. Comparison of a semiquantitative and a morphometric histopathologic scoring system.
The American review of respiratory disease 1992;146(4):1042-7.
1992: Robert Low; M S Giancola; Talmadge E King; J Chapitis; Pamela M Vacek; Gerald S Davis
Serum and bronchoalveolar lavage of N-terminal type III procollagen peptides in idiopathic pulmonary fibrosis.
The American review of respiratory disease 1992;146(3):701-6.
1992: David A Lynch; C S Rose; D Way; Talmadge E King
Hypersensitivity pneumonitis: sensitivity of high-resolution CT in a population-based study.
AJR. American journal of roentgenology 1992;159(3):469-72.
1992: Talmadge E King; R L Mortenson
Cryptogenic organizing pneumonitis. The North American experience.
Chest 1992;102(1 Suppl):8S-13S.
1992: Talmadge E King; R L Mortenson
Bronchoalveolar lavage in patients with connective tissue disease.
Journal of thoracic imaging 1992;7(3):26-48.
1992: E L Kulwiec; David A Lynch; S M Aguayo; Marvin I Schwarz; Talmadge E King
Imaging of pulmonary histiocytosis X.
Radiographics : a review publication of the Radiological Society of North America, Inc 1992;12(3):515-26.
1992: S M Aguayo; Talmadge E King; M A Kane; K M Sherritt; W Silvers; L M Nett; T L Petty; Y E Miller
Urinary levels of bombesin-like peptides in asymptomatic cigarette smokers: a potential risk marker for smoking-related diseases.
Cancer research 1992;52(9 Suppl):2727s-2731s.
1991: P C Carré; R L Mortenson; Talmadge E King; P W Noble; C L Sable; David W H Riches
Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. A potential mechanism for the recruitment and activation of neutrophils in lung fibrosis.
The Journal of clinical investigation 1991;88(6):1802-10.
1991: M E Hanley; Talmadge E King; Marvin I Schwarz; L C Watters; A S Shen; Reuben M Cherniack
The impact of smoking on mechanical properties of the lungs in idiopathic pulmonary fibrosis and sarcoidosis.
The American review of respiratory disease 1991;144(5):1102-6.
1991: Reuben M Cherniack; T V Colby; Andrew Flint; W M Thurlbeck; J Waldron; L Ackerson; Talmadge E King
Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. The BAL Cooperative Group Steering Committee.
The American review of respiratory disease 1991;144(4):892-900.
1991: Francis X McCormack; Talmadge E King; Dennis R Voelker; P C Robinson; Robert J Mason
Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A.
The American review of respiratory disease 1991;144(1):160-6.
1991: R J Shaw; S H Benedict; R A Clark; Talmadge E King
Pathogenesis of pulmonary fibrosis in interstitial lung disease. Alveolar macrophage PDGF(B) gene activation and up-regulation by interferon gamma.
The American review of respiratory disease 1991;143(1):167-73.
1990: S M Aguayo; Talmadge E King; J A Waldron; K M Sherritt; M A Kane; Y E Miller
Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granuloma.
The Journal of clinical investigation 1990;86(3):838-44.
1990: D L Buschman; J A Waldron; Talmadge E King
Churg-Strauss pulmonary vasculitis. High-resolution computed tomography scanning and pathologic findings.
The American review of respiratory disease 1990;142(2):458-61.
1990: R J Panos; R L Mortenson; S A Niccoli; Talmadge E King
Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment.
The American journal of medicine 1990;88(4):396-404.
1989: S M Aguayo; M A Kane; Talmadge E King; Marvin I Schwarz; L Grauer; Y E Miller
Increased levels of bombesin-like peptides in the lower respiratory tract of asymptomatic cigarette smokers.
The Journal of clinical investigation 1989;84(4):1105-13.
1989: Lee Newman; Kathleen Kreiss; Talmadge E King; S Seay; P A Campbell
Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history.
The American review of respiratory disease 1989;139(6):1479-86.
1989: J A Leff; Talmadge E King
Cavitary lung disease with skin lesions.
Chest 1989;95(2):457-8.
1989: David B Badesch; Talmadge E King; Marvin I Schwarz
Acute eosinophilic pneumonia: a hypersensitivity phenomenon?
The American review of respiratory disease 1989;139(1):249-52.
1989: Talmadge E King
Bronchiolitis obliterans.
Lung 1989;167(2):69-93.
1989: D Savici; P A Campbell; Talmadge E King
Bronchoalveolar macrophages from patients with idiopathic pulmonary fibrosis are unable to kill facultative intracellular bacteria.
The American review of respiratory disease 1989;139(1):22-7.
1988: Talmadge E King; D Savici; P A Campbell
Phagocytosis and killing of Listeria monocytogenes by alveolar macrophages: smokers versus nonsmokers.
The Journal of infectious diseases 1988;158(6):1309-16.
1988: T L Dunn; L C Watters; C Hendrix; Reuben M Cherniack; Marvin I Schwarz; Talmadge E King
Gas exchange at a given degree of volume restriction is different in sarcoidosis and idiopathic pulmonary fibrosis.
The American journal of medicine 1988;85(2):221-4.
1988: M Willcox; A Kervitsky; L C Watters; Talmadge E King
Quantification of cells recovered by bronchoalveolar lavage. Comparison of cytocentrifuge preparations with the filter method.
The American review of respiratory disease 1988;138(1):74-80.
1988: P C Robinson; L C Watters; Talmadge E King; Robert J Mason
Idiopathic pulmonary fibrosis. Abnormalities in bronchoalveolar lavage fluid phospholipids.
The American review of respiratory disease 1988;137(3):585-91.
1987: L C Watters; Marvin I Schwarz; Reuben M Cherniack; J A Waldron; T L Dunn; R E Stanford; Talmadge E King
Idiopathic pulmonary fibrosis. Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy.
The American review of respiratory disease 1987;135(3):696-704.
1986: L C Watters; Talmadge E King; Marvin I Schwarz; J A Waldron; R E Stanford; Reuben M Cherniack
A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis.
The American review of respiratory disease 1986;133(1):97-103.
1986: L C Watters; Talmadge E King; Reuben M Cherniack; J A Waldron; R E Stanford; M L Willcox; K L Christopher; Marvin I Schwarz
Bronchoalveolar lavage fluid neutrophils increase after corticosteroid therapy in smokers with idiopathic pulmonary fibrosis.
The American review of respiratory disease 1986;133(1):104-9.